Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...
This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results